Open AccessEffects of hyperinsulinemia on acquired resistance to epidermal growth factor receptor‑tyrosine kinase inhibitor via the PI3K/AKT pathway in non‑small cell lung cancer cells<em> in vitro</em>
Author(s) -
Hsin-Yi Chiu,
Chi-Ming Chiang,
Szu-Peng Yeh,
DeShien Jong,
LeangShin Wu,
ShihKai Hung,
ChihHsien Chiu
Publication year - 2020
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2020.12069
Subject(s) - gefitinib , hyperinsulinemia , cancer research , epidermal growth factor receptor , tyrosine kinase inhibitor , lung cancer , medicine , pi3k/akt/mtor pathway , protein kinase b , tyrosine kinase , insulin resistance , endocrinology , biology , cancer , signal transduction , insulin , receptor , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom